ArticleACS biomaterials science & engineering2025
Fabrication of PCL Blended Highly Aligned Nanofiber Yarn from Dual-Nozzle Electrospinning System and Evaluation of the Influence on Introducing Collagen and Tropoelastin.
Article in ACS biomaterials science & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Conventional electrospinning is a widely used method for creating nanofibrous structures that show promise in skin wound healing. However, the membranes generated through conventional electrospinning techniques lack reproducibility, scalability, and sufficient mechanical strength, ultimately limiting their potential for clinical applications. In this study, we present a new approach for fabricating biomimetic yarn using a dual-nozzle electrospinning system that collects nanofiber yarn from a rotating funnel. Polycaprolactone (PCL) was combined with collagen-I and tropoelastin in the electrospinning solution to provide relevant biochemical cues necessary for human dermal fibroblast (HDF) cells while maintaining structural integrity. The novel yarns exhibited a hierarchical structure akin to collagen fibers forming the dermal layer of the skin. Furthermore, these yarns demonstrated superior mechanical strength compared to conventional electrospun nanofiber webs. Live/dead fluorescence staining and alamarBlue assays revealed that yarns incorporating both collagen-I and tropoelastin supported significantly higher HDF attachment (18.55% at 24 h) and sustained proliferation, increasing 2.93-fold from Day 1 to Day 7, compared to the PCL-only control yarns (9.34% at 24 h; 2.68-fold increase). Scanning electron microscopy (SEM) observations confirmed that cells on protein-containing yarns formed a continuous, smooth cell layer with elongated, spindle-shaped morphology which was aligned along the yarn axis. This highlights the critical role of yarn architecture in guiding cell orientation and organization. The combined biochemical cues from collagen-I and tropoelastin, together with the aligned, twisted yarn architecture, produced scaffolds that not only enhanced cell adhesion and proliferation but also promoted native-like cell alignment and confluence. This synergistic integration of biochemical signaling and structural guidance underscores the potential of these electrospun yarns as advanced dermal scaffolds, offering both mechanical robustness and functional bioactivity for future wound healing and regenerative medicine applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.